Bioextrax AB (publ)
BIOEX.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$109.48M
Close$
$-0.80
134.8% downside
Current Fair Value
134.8% downsideOvervalued by 134.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $109.48 Million |
|---|---|
| Enterprise Value | $102.09 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.45 |
| Beta | 1.43 |
| Outstanding Shares | 47,601,732 |
Return
| Return on Equity | -155.02% |
|---|---|
| Return on Assets | -128.20% |
| Return on Invested Capital | -161.36% |
Valuation & Multiples
| P/E Ratio | -5.3 |
|---|---|
| PEG | -44.32 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 187.33 |
| Enterprise Value to EBIT | -5.28 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$353,000
Average shareholder expectationNext Earnings Call
Expected Date
November 20, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$136,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bioextrax AB (publ)
14 employees
CEO: Edvard Hall Bioextrax AB (publ) focuses on developing and commercializing a groundbreaking, biology-driven extraction system. This advanced technology facilitates the recovery of a variety of valuable materials from bacterial origins, such as biopla...